CHEK2 and endometrial cancer: The existing data illustrate that CHK2 inhibitors have potential antitumor ability and can produce synergistic cytotoxic effects in combination with other drugs, but as one of the research directions in the future, research into their role endometrial cancer needs to be carried out.